share_log

Vir Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SVF Endurance (Cayman) Limited(12.4%),SoftBank Vision Fund (AIV M1) L.P.(12.4%), etc.

Vir Biotechnology | SC 13G/A:超过5%持股股东披露文件(修正)-SVF Endurance (Cayman) Limited(12.4%),SoftBank Vision Fund (AIV M1) L.P.(12.4%)等

美股sec公告 ·  02/13 17:10
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息